MedPath

Phase II study of TS-1 in elderly patients with unresectable non-small cell lung cancer

Phase 2
Conditions
on-small cell lung cancer
Registration Number
JPRN-UMIN000000793
Lead Sponsor
agasaki Thoracic Oncology Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
32
Inclusion Criteria

Not provided

Exclusion Criteria

1) Uncontroled pleural or pericardial effusion 2) Uncontroled brain metastasis 3) Interstitial pneumonitis, pulmonary fibrosis 4) Active infection 5) Uncontroled other disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response rate
Secondary Outcome Measures
NameTimeMethod
Time to progression, safety, survival time
© Copyright 2025. All Rights Reserved by MedPath